POLY-PRED Drug Patent Profile
✉ Email this page to a colleague
When do Poly-pred patents expire, and what generic alternatives are available?
Poly-pred is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in POLY-PRED is neomycin sulfate; polymyxin b sulfate; prednisolone acetate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; polymyxin b sulfate; prednisolone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLY-PRED?
- What are the global sales for POLY-PRED?
- What is Average Wholesale Price for POLY-PRED?
Summary for POLY-PRED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| DailyMed Link: | POLY-PRED at DailyMed |
US Patents and Regulatory Information for POLY-PRED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | POLY-PRED | neomycin sulfate; polymyxin b sulfate; prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 050081-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
